Literature DB >> 23729010

Outcomes of incidentally discovered thyroid nodules referred to a high-volume head and neck surgeon.

Teresa R Kroeker1, Gavin le Nobel, Mazin Merdad, Jeremy L Freeman.   

Abstract

BACKGROUND: Incidental thyroid nodules are commonly found by radiological studies done for other indications. The yearly incidence of thyroid cancer is increasing, in part because of detection of nonpalpable nodules on imaging performed for unrelated issues.
METHODS: All new patients referred to a high-volume thyroid surgeon for thyroid nodules were reviewed between February 2009 and January 2011. Data regarding patient demographics, risk factors, referring physician, radiologic findings, fine-needle aspiration (FNA) results, and management were reviewed.
RESULTS: One hundred thirty-three of 729 patients (18.2%) had a thyroid nodule or nodules incidentally found on ultrasound, MRI, CT, nuclear imaging, or chest x-ray. Fifty-five patients (41.4%) were managed surgically, with 35 (63.6%) of those having thyroid cancer on final surgical pathology.
CONCLUSION: Based on radiologic findings, risk factors, and FNA results, many incidental thyroid nodules can be observed. Incidental thyroid nodules should be evaluated in the same fashion as a palpable thyroid nodule.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  incidental; management; nodules; outcomes; thyroid

Mesh:

Year:  2013        PMID: 23729010     DOI: 10.1002/hed.23273

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  2 in total

1.  Imaging-detected incidental thyroid nodules that undergo surgery: a single-center experience over 1 year.

Authors:  M Bahl; J A Sosa; R C Nelson; J K Hoang
Journal:  AJNR Am J Neuroradiol       Date:  2014-06-26       Impact factor: 3.825

2.  Hürthle cell-predominant thyroid fine needle aspiration cytology: A four risk-factor model highly accurate in excluding malignancy and predicting neoplasm.

Authors:  Lisi Yuan; Christian Nasr; James F Bena; Tarik M Elsheikh
Journal:  Diagn Cytopathol       Date:  2022-06-08       Impact factor: 1.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.